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Abstract Metabolic syndrome is associated with
migraine but there is no study comparing the characteristics
of migraine with and without metabolic syndrome from
Southeast Asia. This study was therefore undertaken to
compare the clinical characteristics of migraine in patients
with and without metabolic syndrome and insulin resis-
tance. 135 consecutive patients with migraine diagnosed on
the basis of International Headache Society criteria were
subjected to clinical evaluation as per ﬁxed protocol.
Headache severity, frequency and functional disability were
recorded. Metabolic syndrome was diagnosed as per
National Cholesterol Education Programme: Adult Treat-
ment Panel III and International Diabetic Federation crite-
ria. Insulin resistance was calculated by homeostases model
assessment. Their age ranged between 14 and 61 years and
108 were females. Metabolic syndrome was present in
31.9% patients and only 13 were obese. Insulin resistance
was present in 11.1%. Metabolic syndrome was correlated
with age, gender, number of triggers, years of headache and
duration of migraine attacks. Insulin resistance correlated
with duration of migraine attacks. From this study, it can be
concluded that metabolic syndrome was present in 31.9% of
the migraineurs which was mainly in elderly who had
longer duration of headache and multiple triggers.
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Introduction
Migraine is a common disorder with overall prevalence of
5–15% [1–3].The prevalence of migraine in females is
higher (6–22%) compared to males (3–7%) [4–6]. The
pathogenesis of migraine is multifactorial and a number of
genetic and environmental factors have been suggested.
Recently, association of migraine with metabolic syndrome
and insulin resistance has been reported [7, 8]. The prev-
alence of migraine was estimated as 11.9% in males and
22.5% in females with metabolic syndrome. Of the com-
ponents of metabolic syndrome diabetes mellitus, increased
waist circumference and body mass index (BMI) were
more frequent in migraine patients compared to those
without migraine. The frequency of hypertension and
dyslipidemia, however, was not signiﬁcantly different [9].
In a population-based study on obesity and migraine
evaluating 30,215 participants whose mean age was
38.4 years including 65% females, revealed lack of asso-
ciation of BMI with the prevalence of migraine but was
associated with the frequency of headache attacks. In the
normal weight group, 4.4% had 10–15 headache days per
month increasing to 5.8% in the overweight and 20.7% in
the morbidly obese [10]. Majority of these studies are from
the western countries where obesity is common. In a
population-based study, 685 women aged 40–74 years
were evaluated for relationship of BMI and migraine. The
proportion of obesity (BMI [30) did not differ in the
women with active migraine, inactive migraine and those
who never experienced migraine. The frequency, duration
and severity of migraine attacks also did not differ between
obese and non-obese migraine patients [11].
On PubMed search using Keywords ‘‘Migraine’’ and
‘‘Metabolic syndrome/insulin resistance/insulin metabo-
lism’’ revealed six articles; two on metabolic syndrome and
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DOI 10.1007/s10194-012-0416-yfour on insulin metabolism in migraine [8, 9, 12–15]. The
incidence of obesity is lower in Asian countries and we
could not ﬁnd any study from Southeast Asia evaluating
the role of metabolic syndrome in migraine. In the present
study, we report the frequency of metabolic syndrome in
migraine patients and compare the clinical characteristics
of migraine in patients with and without metabolic syn-
drome as well as insulin resistance.
Patients and methods
The patients with migraine were recruited from the neu-
rology out patient service of Sanjay Gandhi Postgraduate
Institute, Lucknow, India during January 2009–June 2010.
The diagnosis of migraine was based on International
Headache Society Criteria [16]. The children below
13 years of age were excluded because ours is an adult
neurology service. All the patients were subjected to
medical history and clinical evaluation as per a ﬁxed pro-
tocol. Family history of headache in three generations was
noted. Migraine triggers were enquired using a question-
naire evaluating various exogenous (sun exposure, noise,
cold, hot, weather change, travelling, hair wash, dry hair,
applying hair oil and food items) and endogenous triggers
(physical and mental stress, fasting for 12 h or more,
hunger, sleep deprivation and menstruation). The presence
of mechanical (static and dynamic) and thermal allodynia
was recorded from checklist which included combing hair,
fan air, shower, shaving, resting head on pillow, wearing
neck tie, ornaments, hair clip, scurf, veil and ear ring, hot
and cold during the interview. The extent of allodynia was
categorized into cephalic only and extension to extrace-
phalic region (neck and upper limb). The duration of
migraine in years, its frequency per month, associated
symptoms, functional disability, duration of each attack in
days and response to treatment were evaluated. The severity
of headache was graded on a 0–3 scale (0 = normal,
1 = mild, 2 = moderate, 3 = severe headache). We con-
sidered average severity of headache in the last month. The
functional disability was graded on 0–4 scale [0 = normal,
1 = mild impairment of activities of daily living (ADL),
2 = moderate, 3 = severe and 4 = inability to perform
ADL activities or bedridden state]. Presence of aura and
associated symptoms such as nausea, vomiting, photopho-
bia and phonophobia were also evaluated. The migraine
index was calculated by average number of attacks per
month multiplied by average severity of headache. Cor-
rected migraine index was calculated by migraine index
multiplied by average duration of attack.
Diagnosis of metabolic syndrome was based on National
Cholesterol Education Programme (NCEP): Adult Treat-
ment Panel (ATP) III 2001 [17] and International Diabetic
Federation (IDF) criteria [18], according to which three of
the following criteria were neededincluding central obesity.
1. Central obesity: waist circumference[90 cm in males
and 80 cm in females.
2. Hypertriglyceridemia [150 mg/dl or on speciﬁc
medication.
3. Low HDL cholesterol \40 mg/dl in males and
\50 mg/dl in females.
4. Hypertension: blood pressure [130 systolic or
[85 mm Hg diastolic or speciﬁc medication.
5. Fasting plasma glucose [100 mg/dl or on speciﬁc
medication or previously diagnosed type 2 diabetes.
Insulin resistance and b cell function were calculated in
90 patients by HOMA model [19].
HOMA-IR insulin resistance ðÞ
¼
Fastingbloodsugar   fastinginsulin
405
HOMA-B b cell function ðÞ was calculated as follows :
¼
360   insulin
Fasting blood sugar
  63
The cut-off value of insulin resistance was taken as
[1.77 for the diagnosis of metabolic syndrome [20].
Blood counts, haemoglobin, ESR, platelet count, blood
urea nitrogen, serum creatinine, bilirubin, transaminases
and TSH were carried out. Fasting and 2-h post prandial
blood sugar, lipid proﬁle and insulin level were estimated.
The blood sugar was assayed by autoanalyzer using oxi-
dase–peroxidase method. The insulin was estimated by
immunoradiometric assay using Siemens Medical Solutions
Diagnostic, LA, USA. Patients with high thyroid stimulat-
ing hormone, renal and hepatic failure were excluded.
Statistical analysis
The migraine patients were categorized into those with
metabolic syndrome and those without. The patients were
also categorized into insulin resistant and those without
based on HOMA-IR. The demographic, severity and fre-
quency of migraine, presence of allodynia, aura and trig-
gers were compared in those with and without metabolic
syndrome as well as with and without insulin resistance
using X
2 and independent t’ test. The variables were con-
sidered signiﬁcant if 2-tailed p value was\0.05. The sta-
tistical analysis was done using SPSS 15 version software.
Results
There were 135 patients with migraine whose mean age
was 31.4 (SD 10.5) years; 108 of whom were females.
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123Family history of migraine was present in 58 patients. The
mean duration of headache was 8.5 (SD 6.7) years. Only
seven patients had migraine with aura. The frequency of
migraine ranged between 2 and 30 attacks per month; 54 of
them had headache frequency of more than 15 attacks per
month. Mechanical (static and dynamic) allodynia was
present in 116 (85.9%) and 27 (20%) of them also had
thermal allodynia. The allodynia was cephalic in 43
(37.1%) and extended to extracephalic region in 73
(62.9%) patients. The majority of patients [134 (99.3%)]
had moderate to severe headache. The general character-
istics of the patients are provided in Table 1.
Metabolic syndrome
The BMI was above 30 in 13 (9.6%) patients and between
25 and 30 in 26 (19.3%). Female patients were more
overweight compared to males (34 vs. 5) and 2 females
were morbidly obese (BMI[35). Waist circumference was
abnormal in 78 (57.8%) patients. HDL was reduced in 108
(80%) and triglyceride was increased in 28 (20.7%)
patients. Fasting blood sugar was high in 13 (9.6%) patients.
The systolic blood pressure was raised in 15 and diastolic in
33 (24.5%) patients. Insulin resistance (HOMA-IR) was
present in 10 (11.1%) patients. b cell function (HOMA-B)
was 179.3 ± 552.4. Based on ATP-III and IDF criteria, 43
(31.9%) patients had metabolic syndrome. Out of 5 com-
ponents of metabolic syndromes, all 5 were present in 3, 4
in 14 and 3 in 26 patients. Only 2 components of metabolic
syndrome were present in 40 patients, however they were
not diagnosed as metabolic syndrome.
Correlation
The patients with metabolic syndrome were older (p =
0.0001), more frequently females (p = 0.01), had longer
duration of illness (10.3 ± 7.5 vs. 7.6 ± 6.2, p =
0.03), higher number of triggers (11.6 ± 2.5 vs. 10.5 ±
2.8, p = 0.03) and longer duration of attack (2.0 ± 0.8 vs.
1.7 ± 0.8, p = 0.05) compared to those without metabolic
syndrome. The majority of patients had multiple triggers;
commonest being noise in 129 (95.6%) followed by stress
in 128 (94.8%), sunlight in 121 (89.6%) and fasting in 100
(74.1%) patients. On comparing the triggers, head wash
was more frequent in those with metabolic syndrome
compared to without (65.1% vs. 44.6%; p = 0.03). The
details of triggers are given in Table 2. The presence of
aura (3 vs. 4, p = 0.68), frequency of headache (15.1 ±
11.1 vs. 15.5 ± 10.6, p = 0.82), severity of migraine
(p = 0.66), migraine index (MI) (30.8 ± 22.6 vs. 37.0 ±
28.0, p = 0.20), corrected migraine index (MIc) (55.8 ±
39.4 vs. 54.6 ± 40.0, p = 0.87), functional impairment
(p = 0.19), presence of allodynia (p = 0.79) and extent of
allodynia (p = 0.84) were not signiﬁcantly different
between the two groups (Table 3). Insulin resistance
(HOMA-IR [1.77) was present in 10 (11.1%) patients.
There was no difference in demography, duration of
migraine, migraine index, corrected migraine index, num-
ber of triggers, and fasting and hunger as triggers between
the two groups (Table 4). The duration of migraine attack
was more in the patients with insulin resistance (p = 0.04).
Discussion
In the present study, 31.9% of the migraine patients had
metabolic syndrome but only 9.6% were obese. The diag-
nosis of metabolic syndrome was based on increased waist
circumference (57.8%), hypertriglyceridemia (20.7%),
hypertension (27.4%), low HDL (80.0%) and increased
Table 1 Demography and clinical characteristics of migraine
patients
Parameters Number of patients (n = 135)
Age (years) 31.41 ± 10.5 (range 14–61)
Female 108 (80%)
Urban/rural 81/54
Education (years) 10.36 ± 5.02
Family history of headache 58 (43%)
Total family members affected 1.66 ± 0.9 (range 1–6)
Only patients 77 (57%)
1st generation 33 (24.4%)
2nd generation 23 (17%)
3rd generation 2 (1.5%)
Migraine with aura 7 (5.2%)
Duration (years) 8.48 ± 6.7 (range 0.5–40)
Frequency/months 15.4 ± 10.7 (range 2–30)
Duration attack (days) 1.8 ± 0.8 (range 0.5–4)
Total no. of triggers 10.84 ± 2.78 (range 2–15)
Allodynia 116 (85.9%)
Mechanical 116 (85.9%)
Static 116 (85.9%)
Dynamic 115 (85.2%)
Thermal 27 (20%)
Cephalic 43 (37.1%)
Extracephalic 73 (62.9%)
Number of metabolic parameters abnormality (0–5)
0 11 (8.1%)
1 41 (30.4%)
2 40 (29.6%)
3 26 (19.3%)
4 14 (10.4%)
5 3 (2.2%)
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123fasting blood sugar (9.6%). Moreover, insulin resistance
was present in 11.1% patients. These observations are in
agreement with the reports from the western countries in
which metabolic syndrome has been associated with
migraine [7, 9, 21]. In our study, only 2 patients were
morbidly obese and remaining 11 patients were obese. In a
study from USA, the effect of BMI on the prevalence of
severe headache or migraine revealed signiﬁcant associa-
tion of headache or migraine with low (\18.5 kg/m
2) and
high BMI ([30 kg/m
2)[ 22]. In Asians, central obesity is
Table 2 Frequency of different
triggers migraine and its
comparison in the patients with
and without metabolic
syndrome
Triggers Total number of patients (%) Metabolic syndrome Metabolic syndrome p value
Present Absent
N = 43 (31.9%) N = 92 (68.1%)
Physical stress 128 (94.8) 41 87 1.00
Mental stress 128 (94.8) 40 88 0.70
Fasting 100 (74.1) 36 64 0.09
Hunger 100 (74.1) 36 64 0.09
Sunlight 121 (89.6) 41 80 0.22
Noise 129 (95.6) 43 86 0.18
Cold exposure 81 (60) 23 58 0.35
Hot exposure 100 (74.1) 34 66 0.41
Weather change 104 (77) 35 69 0.51
Menstruation 35 (30.7) 12 23 1.00
Sleep deprivation 119 (88.1) 40 79 0.27
Food 6 (4.4) 3 3 0.38
Travel 116 (85.9) 40 76 0.12
Perfume 33 (24.4) 11 22 0.83
Hair oil 3 (2.2) 1 2 1.00
Head wash 69 (51.1) 28 41 0.03
Dry hair 88 (65.2) 33 55 0.08
Table 3 Comparison of clinical
characteristics in patients with
and without metabolic
syndrome
Parameters Metabolic syndrome Metabolic syndrome p value
Present Absent
N = 43 (31.9%) N = 92 (68.1%)
Age (years) 37.8 ± 7.7 28.4 ± 10.3 \0.0001
Female 40 (93%) 68 (73.9%) 0.01
Urban/rural 26/17 55/37 1.00
Education (years) 9.35 ± 4.76 10.84 ± 5.09 0.11
Family history of headache 22 (51.2%) 36 (39.1) 0.20
Total family members affected 1.86 ± 1.15 1.57 ± 0.79 0.08
Migraine with aura 3 (7%) 4 (4.4%) 0.68
Duration (years) 10.28 ± 7.5 7.64 ± 6.21 0.03
Total no. of triggers 11.58 ± 2.53 10.49 ± 2.84 0.03
Fasting 36 (83.7%) 64 (69.6%) 0.09
Hunger 36 (83.7%) 64 (69.6%) 0.09
Onset to peak time (min) 32.09 ± 32.68 27.61 ± 20.17 0.33
Frequency/months 15.07 ± 11.05 15.52 ± 10.58 0.82
Duration attack (days) 2.0 ± 0.75 1.72 ± 0.78 0.05
Severity of headache 2.98 ± 0.15 2.93 ± 0.29 0.37
Functional impairment 3.28 ± 0.7 3.2 ± 0.62 0.48
Rescue analgesics/mo 13.07 ± 9.82 14.03 ± 11.58 0.64
Allodynia 38 (88.4%) 78 (84.8%) 0.79
Migraine index (MI) 30.75 ± 22.59 37.03 ± 27.97 0.20
Corrected MI (MIc) 55.83 ± 39.43 54.6 ± 40.04 0.87
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123common and was present in 57.8% of our patients. Central
obesity, high triglyceride and low HDL are reported to be
the main component of metabolic syndrome in the Asians
[23], whereas in the western countries high BMI is more
common [13, 24].
Metabolic syndrome is associated with insulin resis-
tance. The patients with migraine have signiﬁcantly higher
level of fasting glucose and insulin; both of which remain
elevated after glucose loading suggesting insulin resistance
[14]. Similar observations have also been reported in a
smaller study in which oral glucose tolerance test and
plasma glucose were signiﬁcantly higher in migraine
patients compared to controls. Insulin sensitivity is sig-
niﬁcantly altered in migraine patients as measured by ISI-
Stumvoll and OGIS-180 index [8]. Insulin resistance is a
state in which normal amount of insulin produces a sub-
normal physiological response. Insulin resistant state may
increase free fatty acids and blood lipids which may induce
migraine attack [25]. Low HDL is an important component
of metabolic syndrome and HDL has anti-inﬂammatory
property. Reduced LDL may reduce pain perception [26].
In our study, metabolic syndrome was signiﬁcantly
related to age. The mean age in the patients with metabolic
syndrome was 37.8 (SD 7.7) years, whereas it was 28.4
(SD 10.3) years in those without. Age may be directly
related to various components of metabolic syndrome such
as obesity, hypertension, glucose intolerance and hyper-
lipidemia which may be an association rather than under-
lying mechanism. In our study, metabolic syndrome and
migraine both were more common in females than males.
Whether it is merely an association or it has a biological
basis needs further study. Migraine is precipitated by a
number of endogenous and exogenous triggers. Fasting and
hunger are important triggers and have been reported in
Indian subjects in 46.3% [27]. Fasting is common in both
Hindus and Muslims as a religious practice. In the present
study, the most common trigger was noise (95.6%) fol-
lowed by stress (94.8%), sun exposure (89.6%) and fasting
(74.1%). Fasting results in activation of insulin receptors
which may trigger a migraine attack [28]. Low sucrose
diets may reduce the frequency of migraine attack [29]. In
migraineurs, the onset of diabetes mellitus increases the
average yearly number of headache days [30]. In our study,
fasting was neither associated with metabolic syndrome
nor with insulin resistance but the duration of migraine
attack (days) was signiﬁcantly related to insulin resistance.
Our results are limited by absence of a control group,
absence of children, disproportionately large number of
females and unequal number of patients with and without
metabolic syndrome. In a population-based study from
North India, the prevalence of metabolic syndrome is
67.2% (male 75.9% and female 58.4%) and obesity in
Table 4 Comparison of clinical
characteristics in patients with
and without insulin resistance
(HOMA-IR[1.775)
Parameters Insulin resistance Insulin resistance p value
Present Absent
N = 10 (11.1%) N = 80 (88.9%)
Age (years) 33.0 ± 9.04 31.39 ± 10.98 0.66
Female 8 (80%) 62 (77.5%) 1.00
Urban/rural 6/4 45/35 0.81
Education (years) 11.0 ± 3.86 10.05 ± 5.06 0.57
Migraine with aura 0(%) 6 (7.5%) 0.37
Duration (years) 9.98 ± 6.30 8.40 ± 7.48 0.52
Total no. of triggers 10.9 ± 3.45 11.15 ± 2.54 0.78
Fasting 7 (70%) 59 (73.8%) 0.72
Hunger 7 (70%) 59 (73.8%) 0.72
Onset to peak 28.0 ± 13.78 27.00 ± 17.73 0.86
Severity of headache 3.00 ± 00 2.95 ± 0.27 0.56
Severity of functional impairment 3.10 ± 0.88 3.16 ± 0.63 0.78
Frequency/months 16.00 ± 12.27 13.53 ± 10.7 0.50
Duration attack (days) 2.42 ± 0.66 1.90 ± 0.78 0.04
Rescue analgesics/months 17.10 ± 14.43 12.39 ± 9.77 0.18
Allodynia 9 (90%) 69 (86.3%) 1.00
Family history of headache 6 (60%) 31 (38.6%) 0.31
Migraine index (MI) 35.40 ± 25.97 31.46 ± 25.98 0.65
Corrected MI (MIc) 75.26 ± 42.07 52.65 ± 43.01 0.12
No. of metabolic parameters
abnormality (metabolic syndrome)
3.70 ± 1.16 1.48 ± 0.98 \0.0001
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12379.3% (male 74.5% and female 84.0%) [31]. The lower
frequency of metabolic syndrome and obesity in our study
compared to the above-mentioned study may be due to the
referral bias. The study by Yadav et al. [31] was based on
urban afﬂuent population. We have studied migraine
patients from different regions of North India including
both urban and rural population comprising diverse
socioeconomic classes.
Based on our results, it can be concluded that migraine is
associated with metabolic syndrome in 31.9% and insulin
resistance in 11.1% patients. The patients with metabolic
syndrome are older, have multiple triggers, longer history of
migraine as well as duration of migraine attack. A larger
controlled study is needed to conﬁrm these results.
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